Polyethylenimine Linear (PEI, MW 40,000): High-Efficiency DNA Transfection Reagent for In Vitro Applications

Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a widely used DNA transfection reagent with a linear polymer structure and a molecular weight of 40,000 Daltons. It condenses negatively charged DNA to form positively charged complexes that facilitate endocytosis-mediated cellular uptake (Roach 2024, DigitalCommons@Pace). PEI-mediated transfection is compatible with serum-containing media and yields 60–80% efficiency in standard mammalian cell lines. The reagent is scalable from small (96-well) to large (100 L bioreactor) formats. Correct storage (4°C for frequent use; -20°C for long-term) and avoidance of repeated freeze-thaw cycles are crucial for maintaining activity (ApexBio K1029).

Biological Rationale

Efficient transfection is foundational to modern molecular and cell biology. Delivery of plasmid DNA or mRNA into mammalian cells enables gene expression studies, recombinant protein production, and functional assays. Polyethylenimine Linear (PEI, MW 40,000) is engineered for high charge density and linearity, enhancing its ability to condense nucleic acids. This property is critical for forming stable, nano-sized complexes suitable for cellular uptake (Roach 2024). The reagent’s compatibility with serum-containing media allows for direct use in standard cell culture conditions, reducing cytotoxicity and simplifying workflows. PEI’s robust performance in diverse cell lines, including HEK-293, HEK293T, CHO-K1, HepG2, and HeLa, makes it a gold standard for transient gene expression and protein production (Polyethylenimine Linear: Strategic Advances).

Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

PEI Linear is a cationic polymer composed of repeating ethylenimine units. Its positive charge results from protonated amine groups along the backbone. Upon mixing with negatively charged DNA, PEI neutralizes and condenses the DNA into compact, positively charged polyplexes. These polyplexes interact electrostatically with the anionic cell surface, particularly proteoglycans. Cellular uptake occurs predominantly via endocytosis, enabling efficient internalization of nucleic acid payloads (PEI Linear: DNA Transfection Technology). Intracellularly, the "proton sponge effect" of PEI promotes endosomal escape, facilitating nucleic acid release into the cytoplasm or nucleus for gene expression (PEI MW 40,000: Optimizing DNA Transfection).

Evidence & Benchmarks

• Transfection efficiency with PEI, MW 40,000 in HEK-293 cells ranges from 60% to 80% in serum-containing DMEM at 37°C, 5% CO₂ (Roach 2024, DigitalCommons@Pace).
• DNA:PEI complexation achieves optimal particle size (~100–200 nm) for endocytosis, as measured by Dynamic Light Scattering (DLS) (Roach 2024, Table 2).
• PEI-mediated transfection is compatible with FBS concentrations up to 10%, with no significant drop in cell viability or efficiency (Expert Insights).
• Recombinant protein yield in CHO-K1 cells can be scaled from 1 mL to 100 L bioreactor volumes using PEI, MW 40,000 (ApexBio K1029).
• PEI Linear supports co-delivery of DNA and mRNA in mesoscale nanoparticles for targeted organ delivery (Roach 2024, Fig. 4).

Applications, Limits & Misconceptions

PEI, MW 40,000 is validated for routine transient transfection in research settings. It is widely used for recombinant protein production, gene function studies, and high-throughput screening. The reagent is compatible with adherent and suspension cell lines, including HEK-293 derivatives, CHO, HeLa, and HepG2. Large-scale manufacturing applications leverage its scalability and batch-to-batch consistency (PEI Linear: Next-Gen Transfection). Unlike some cationic lipids, PEI Linear maintains efficiency in the presence of serum, reducing cytotoxicity concerns in standard workflows.

Common Pitfalls or Misconceptions

• Not suitable for in vivo gene delivery: PEI, MW 40,000 is optimized for in vitro use; in vivo applications require further safety and pharmacokinetic validation (Roach 2024).
• Overloading DNA or PEI: Excess reagent can increase cytotoxicity without improving transfection (Troubleshooting Strategies).
• Repeated freeze-thaw cycles: These degrade polymer activity; storage at 4°C (short-term) or -20°C (long-term) is recommended (ApexBio K1029).
• Not a universal solution: Some primary or sensitive cell types may require alternative reagents (PEI Linear: Technology Limitations).

Workflow Integration & Parameters

PEI Linear is supplied at 2.5 mg/mL in 4 mL and 8 mL vials. For typical protocols, a DNA:PEI ratio (mass:mass) of 1:2 to 1:3 is used. Complex formation is performed in isotonic buffer (e.g., 150 mM NaCl) at room temperature for 10–20 minutes. The mixture is then added directly to cultured cells. Transfection is possible in 96-well, 6-well, T-flask, or large stirred-tank bioreactor formats. After 4–6 hours, media can be replaced to minimize cytotoxicity. Protein or gene expression is typically measured 24–72 hours post-transfection (Polyethylenimine Linear (PEI, MW 40,000)).

For advanced workflow design, see Engineering the Future of Transient Gene Expression, which expands on epigenetic and disease model applications; this article provides a more focused product-specific protocol and benchmark dataset.

Conclusion & Outlook

Polyethylenimine Linear (PEI, MW 40,000) remains a central tool in molecular biology for reliable, scalable DNA transfection. Its established mechanism supports robust gene expression and recombinant protein production in vitro. Ongoing research is refining formulation and delivery for targeted and large-scale applications. For validated protocols, product specifications, and purchase, see the ApexBio K1029 product page.